Svas Biosana S.p.A. (BIT:SVS)
7.36
-0.24 (-3.16%)
At close: May 9, 2025, 5:30 PM CET
Svas Biosana Revenue
In the year 2024, Svas Biosana had annual revenue of 120.31M EUR, down -1.08%. Svas Biosana had revenue of 59.04M in the half year ending June 30, 2024, with 32.10% growth.
Revenue
120.31M
Revenue Growth
-1.08%
P/S Ratio
0.35
Revenue / Employee
367.94K
Employees
323
Market Cap
42.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 120.31M | -1.32M | -1.08% |
Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.41B |
DiaSorin | 1.21B |
Amplifon | 2.42B |
Philogen | 77.65M |
EL.En. | 565.85M |
Pharmanutra | 116.15M |
Garofalo Health Care | 467.77M |
Safilo Group | 993.22M |